NEJM· @NEJM · X·· 25 天前精选AI 评分75
AI 导读
NEJM发布III期RAINIER AIS-D08试验结果,在IgA肾病患者中,BAFF与APRIL双抑制剂povetacicept较安慰剂显著降低蛋白尿。完整结果已在#KidneyWk公布,链接为https://nej.md/3VWcGh6。
推荐理由
原文给出III期RAINIER试验中povetacicept较安慰剂显著降低IgA肾病患者蛋白尿的结果,可供对照同类在研疗法。
正文
Presented at #KidneyWk:
Among participants with IgA nephropathy, povetacicept, a dual inhibitor of B-cell activating factor and a proliferation-inducing ligand, led to a significantly greater reduction in proteinuria than placebo. Full phase 3 RAINIER AIS-D08 trial results: https://nej.md/3VWcGh6
@ASNKidney
来源:NEJM · x.com